|

SAR447537 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Sanofi1

Indications

  • Alpha 1-Antitrypsin Deficiency1
  • Liver Disease1
  • Emphysema1

Birmingham, Alabama1 trial

Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema

UAB Lung Health Center- Site Number : 105

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.